Importantly, EMT can involve cancer cells to varying degrees, i.e., some cells will retain many epithelial characteristics, while others will completely acquire a mesenchymal phenotype, expressing mesenchymal markers such as alpha-smooth muscle (α-SMA), ferroptosis suppressor protein 1 (FSP1), vimentin, and desmin [22,30]. Here, AIFM2 is linked to cancer.